ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 984,93
-0,99%
Dow Jones
37 815,92
-1,49%
DAX
17 932,17
-1,10%
Brent Oil
85,40
-0,58%
Bitcoin
57 198,50
-5,58%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. ATAI Life Sciences NV (ATAI)

  7. ATAI Life Sciences NV (ATAI) Actualités

ATAI ATAI Life Sciences NV

1,98
0,00 (0,00%)
Avant marché
Dernière mise à jour : 10:00:00
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
ATAI Life Sciences NV ATAI NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 1,98 10:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,98
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
24/4/202413:00GLOBEatai Life Sciences Announces Dosing of First Patient in Part..
17/4/202413:00GLOBEatai Life Sciences Announces the Publication of Beckley..
28/3/202412:00GLOBEatai Life Sciences Reports Fourth Quarter and Full Year 2023..
27/3/202412:00GLOBEatai Life Sciences Announces Positive Initial Results from..
04/3/202414:00GLOBEatai Life Sciences Announces First Participant Dosed in..
28/2/202423:00GLOBEatai Life Sciences to Participate in the Upcoming TD Cowen..
13/2/202422:29EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/2/202423:05EDGAR2Form 8-K - Current report
06/2/202423:00GLOBEatai Life Sciences Appoints Anne Johnson as Chief Financial..
23/1/202413:46EDGAR2Form 8-K - Current report
09/1/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202422:28EDGAR2Form 8-K - Current report
04/1/202414:53EDGAR2Form 8-K - Current report
04/1/202413:20EDGAR2Form 8-K - Current report
04/1/202413:00GLOBEatai Life Sciences Announces Strategic Investment in Beckley..
02/1/202414:00GLOBEatai Life Sciences Announces Positive Topline Results from..
20/11/202315:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202313:03GLOBEatai Life Sciences Reports Third Quarter 2023 Financial..
13/10/202322:15EDGAR2Form 8-K - Current report
10/10/202314:00PRNCAATAI LIFE SCIENCES ANNOUNCES FILING OF EARLY WARNING REPORT
06/10/202322:05GLOBEatai Life Sciences to Participate in the Jefferies Inaugural..
02/10/202322:13GLOBEatai Life Sciences Announces Completion of Phase 1 Study of..
29/9/202322:38EDGAR2Form 8-K - Current report
14/9/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/9/202314:02GLOBEatai Life Sciences to Participate in the 2023 Cantor..
06/9/202322:01GLOBEatai Life Sciences to Participate in Upcoming September..
31/8/202322:17EDGAR2Form 8-K - Current report
10/8/202322:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202313:42EDGAR2Form 8-K - Current report
10/8/202312:59GLOBEatai Life Sciences Reports Second Quarter 2023 Financial..
08/8/202322:02GLOBEatai Life Sciences Announces Results from the Phase 1..
01/6/202315:10GLOBEAtossa Appoints Life Sciences Financial and Operations..
01/6/202312:59GLOBEatai Life Sciences to Participate in Upcoming June Investor..
11/5/202312:59GLOBEatai Life Sciences Reports First Quarter 2023 Financial..
02/5/202323:20GLOBEatai Life Sciences to Participate in Upcoming May Investor..

Dernières Valeurs Consultées

NASDAQ
ATAI
ATAI Life Sciences NV
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés